Trial0

Clinical trial · NCT06728436 · RECRUITING · NA

Testing the Effects of a Text Message Caregiver Support Intervention for Latinos

Sponsor: University of Kansas Medical Center

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

The goal of this randomized clinical trial it to test the efficacy of CuidaTEXT, the first Alzheimer's disease and Related Dementias (ADRD) caregiver support intervention to capitalize on text messaging, among Latinos. Researchers will compare those who receive the CuidaTEXT intervention to those who do not receive the intervention to see if CuidaTEXT effects Latino caregiver stressors and their negative consequences . Participants will receive a variety of text messages, from automatic to keyword-drive, regarding ADRD education, social support, self-care, ADRD care management, and behavioral symptoms. Participants will also complete measures regarding depressive symptoms, coping, behavioral symptoms, and preparedness for caregiving.

Interventions

  • CuidaTEXT · BEHAVIORAL

    CuidaTEXT is a multidomain, bilingual 6-month text message intervention that includes delivery and content features tailored to Latino caregivers. All caregivers receive one core daily automatic message on five domains: ADRD education, social support, self-care, ADRD care management, and behavioral symptoms. Caregivers can access on-demand automatic messages to expand on the five domains via sending keywords and interact with a coach via a live chat for more personalized help.

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Over the age of 18
* Spanish and English-speaking people who identify as Latino
* Reports providing hands-on care for a relative who has been given a clinical or research ADRD diagnosis and has an Eight-item Informant Interview to Differentiate Aging and Dementia (AD-8) screening score ≥2, indicating cognitive impairment
* Has a score of 7 or higher on the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)
* Self-reports being able to read and write
* Owns a cell phone with a flat fee, and uses it at least weekly for texting.

Exclusion Criteria:

* Participation in another wellbeing-related clinical trial
* Cohabitation with another participant in the CuidaTEXT R01 Study
* Participants who provide care for a person with ADRD already cared for by another participant in the CuidaTEXT R01 study
* Participant plans to move to another country within seven months

Sites (1)

  • University of Kansas Medical Center, Fairway, Kansas · RECRUITING

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2025-12-11.